Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

Tonix
Tonix Reports Q2 2026 Financial Results and Operational Highlights

Tonix Pharmaceuticals announced that TONMYA net sales increased 197% quarter-over-quarter to approximately $11 million. The company also reported appr...

MoonLake
MoonLake's sonelokimab met all key PsA endpoints in Phase 3 trial.

MoonLake Immunotherapeutics reported positive results from its Phase 3 IZAR-1 trial for sonelokimab in psoriatic arthritis, alongside cash runway proj...

Sionna
Sionna's SION-719 CF Program Misses Key Endpoint

Sionna missed the key activity endpoint for the SION-719 proof-of-concept trial, canceling development as an add-on to Trikafta. Despite the setback, ...

Jade
Jade Biosciences Q2 Results: JADE101 Positive, Cash $461M

Jade Biosciences reported positive Phase 1 data for JADE101 and announced the start of a Phase 2 trial, bolstered by robust cash reserves expected to ...

SIFCO
SIFCO Industries sees 18.3% net sales rise in Q3 2026

SIFCO Industries reported net sales of $26.1 million for Q3, up 18.3%, and net income of $4.4 million for the first nine months. The company achieved ...

AAON,
AAON reports record Q2 2026 sales and earnings growth

AAON reported a 101% increase in Q2 net sales to a record $627 million, driven by demand and operational execution. The company raised its full-year 2...

CEVA
Ceva posts highest licensing revenue in three years on AI demand

Ceva Inc reported Q2 2026 financial results with total revenue up 13% and licensing revenues up 21%, the highest in three years, driven by demand for ...

NEWS
News Corp buys back up to $30M of stock

News Corp updated its capital management strategy with a repurchase program. This action signals confidence in its financial performance and aims to e...

SHOULDER
Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officer

Shoulder Innovations, Inc. (SI) has promoted Jon Osborne to Chief Commercial Officer, effective August 6, 2026. This leadership change is a key strate...

OPAL
OPAL Fuels Posts Higher Q2 2026 EBITDA

OPAL Fuels reported second-quarter 2026 adjusted EBITDA of $39.8 million and confirmed it remains on track for its annual guidance despite flat RIN pr...

Arbiter
13F-HR - Arbiter Partners Capital Management LLC (0001513193) (Filer)

Institutional holdings report (13F-HR) filed by Arbiter Partners Capital Management LLC....

Aquestive
Aquestive reports positive human factors and PK results for Anaphylm film

Aquestive Therapeutics announced positive human factors and pharmacokinetic study results for its Anaphylm (dibutepinephrine) sublingual film, support...

Village
Village Farms Records Record Q2 2026 Net Sales and Net Income

Village Farms International reported Q2 2026 results with a 27% sequential increase in net sales to $64 million and net income of $7.1 million, driven...

Axsome
Axmore reports 46% Q2 2026 product revenue growth to $218.4 million

Axmore reported Q2 2026 financial results with AUVELITY and SUNOSI driving growth, alongside clinical advances in its neuroscience pipeline....

Target
Target Hospitality reports Q2 revenue up 39%; raises fiscal 2026 outlook

Target Hospitality announced second-quarter revenue of $85.5 million and significant growth in contract awards and liquidity. The company raised its f...

TPG
TPG Mortgage Investment Trust reports Q2 2026 results, announces dividend and acquisition of Cherry Hill

TPG Mortgage Investment Trust reported second quarter 2026 financial results, increasing book value and offering a dividend. The company also announce...

N-able,
N-able Q2 2026 Arr Growth of 6%

N-able reported Q2 2026 revenue of $138.2 million, representing 5.9% year-over-year growth and an updated ARR outlook of $562M to $565M....

CECO
CECO Reports Q2 2026 Results with Record Orders and Increased Backlog

Ceco Environmental reported record-setting second quarter 2026 results driven by a 191% increase in orders and growth ahead of expectations following ...

LINCOLN
Lincoln Financial Names Adam Cohen Interim CFO

Chris Neczypor is stepping down as CFO. Adam Cohen, the Chief Accounting Officer, will serve as interim. Lincoln Financial is searching for a permanen...

Oruka
Oruka Therapeutics Q2 Financial Results & Updates on ORKA-001 & ORKA-002 Programs

Oruka Therapeutics reported Q2 financial results and updated clinical pipelines, advancing multiple programs with key data readouts expected in late 2...